A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
Abstract Identifying women at high risk of osteoporotic fracture from aromatase inhibitor (AI) therapy for breast cancer is largely based on known risk factors for healthy postmenopausal women, which might not accurately reflect the risk in breast cancer patients post-AI therapy. To determine whethe...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Nature Portfolio
2024-01-01
|
| Rangatū: | npj Breast Cancer |
| Urunga tuihono: | https://doi.org/10.1038/s41523-024-00615-9 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|